Two Sigma Securities’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$165K Buy
+24,326
New +$180K 0.02% 1089
2024
Q1
Sell
-22,244
Closed -$83.6K 3063
2023
Q4
$83.6K Buy
+22,244
New +$76.5K ﹤0.01% 2542
2021
Q2
Sell
-10,840
Closed -$108K 1519
2021
Q1
$108K Buy
+10,840
New +$114K 0.01% 691
2018
Q2
Sell
-15,764
Closed -$14K 2690
2018
Q1
$14K Buy
+15,764
New +$31.5K ﹤0.01% 2592

Other funds holding CRMD

Two Sigma Securities's CRMD Position: Q1 2026 in Review

Two Sigma Securities opened a new position in CorMedix (CRMD) in Q1 2026: 24,326 shares worth $165K. The stake represents 0.02% of the portfolio and ranks #1089 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in CRMD as recently as Q4 2023.

Two Sigma Securities first reported a position in CRMD in Q1 2018 and has held it in 4 quarters since. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Two Sigma Securities held 24,326 shares of CorMedix worth $165K as of Q1 2026.
  • CorMedix was a new Two Sigma Securities position in Q1 2026.
  • CorMedix made up 0.02% of Two Sigma Securities's portfolio in Q1 2026, its #1089 holding.
  • Two Sigma Securities first reported a position in CorMedix in Q1 2018 and has held it in 4 quarters since.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.